Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US

Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US Opinion EDITORIAL Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US Paul J. Joudrey, MD, MPH; E. Jennifer Edelman, MD, MHS; Emily A. Wang, MD In 1974, President Nixon signed the Narcotic Addiction Treat- This methadone landscape within the US has led to calls ment Act, which gave statutory authority to the regulations for federal action to enable the integration of methadone into governing the provision of methadone for the treatment of opi- primary care and to widen options for observed medication 2,6 oid use disorder (OUD) in the US. The original name for the bill dispensing. Recent data support these changes in regula- was revealing: the Metha- tion as a way of improving methadone access. Our 2019 study done Diversion Control Act. published in JAMA found, using geographical information sys- Related article page 1163 These regulations that were tem technology, that the urban-rural disparity in drive time to meant to restrict dispensation on methadone have under- methadone could be mitigated if methadone provision oc- gone only modest revision over the ensuing decades even in curred within federally qualified health centers. 1 7 the midst of a current overdose epidemic. In the US, metha- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Psychiatry American Medical Association

Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US

Loading next page...
 
/lp/american-medical-association/methadone-for-opioid-use-disorder-decades-of-effectiveness-but-still-2p8gbp9vus
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2168-622X
eISSN
2168-6238
DOI
10.1001/jamapsychiatry.2020.1511
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US Paul J. Joudrey, MD, MPH; E. Jennifer Edelman, MD, MHS; Emily A. Wang, MD In 1974, President Nixon signed the Narcotic Addiction Treat- This methadone landscape within the US has led to calls ment Act, which gave statutory authority to the regulations for federal action to enable the integration of methadone into governing the provision of methadone for the treatment of opi- primary care and to widen options for observed medication 2,6 oid use disorder (OUD) in the US. The original name for the bill dispensing. Recent data support these changes in regula- was revealing: the Metha- tion as a way of improving methadone access. Our 2019 study done Diversion Control Act. published in JAMA found, using geographical information sys- Related article page 1163 These regulations that were tem technology, that the urban-rural disparity in drive time to meant to restrict dispensation on methadone have under- methadone could be mitigated if methadone provision oc- gone only modest revision over the ensuing decades even in curred within federally qualified health centers. 1 7 the midst of a current overdose epidemic. In the US, metha-

Journal

JAMA PsychiatryAmerican Medical Association

Published: Nov 15, 2020

References